JP6443040B2 - Skin cosmetics - Google Patents
Skin cosmetics Download PDFInfo
- Publication number
- JP6443040B2 JP6443040B2 JP2014263674A JP2014263674A JP6443040B2 JP 6443040 B2 JP6443040 B2 JP 6443040B2 JP 2014263674 A JP2014263674 A JP 2014263674A JP 2014263674 A JP2014263674 A JP 2014263674A JP 6443040 B2 JP6443040 B2 JP 6443040B2
- Authority
- JP
- Japan
- Prior art keywords
- skin
- acid
- mass
- makeup
- effect
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000002537 cosmetic Substances 0.000 title claims description 48
- PORPENFLTBBHSG-MGBGTMOVSA-N 1,2-dihexadecanoyl-sn-glycerol-3-phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(O)=O)OC(=O)CCCCCCCCCCCCCCC PORPENFLTBBHSG-MGBGTMOVSA-N 0.000 claims description 19
- 150000003839 salts Chemical class 0.000 claims description 13
- HOVAGTYPODGVJG-UVSYOFPXSA-N (3s,5r)-2-(hydroxymethyl)-6-methoxyoxane-3,4,5-triol Chemical compound COC1OC(CO)[C@@H](O)C(O)[C@H]1O HOVAGTYPODGVJG-UVSYOFPXSA-N 0.000 claims description 12
- HOVAGTYPODGVJG-UHFFFAOYSA-N methyl beta-galactoside Natural products COC1OC(CO)C(O)C(O)C1O HOVAGTYPODGVJG-UHFFFAOYSA-N 0.000 claims description 12
- -1 polyoxyethylene Polymers 0.000 claims description 11
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 10
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 claims description 9
- 125000002252 acyl group Chemical group 0.000 claims description 9
- 125000004432 carbon atom Chemical group C* 0.000 claims description 7
- 230000000694 effects Effects 0.000 description 29
- 235000014113 dietary fatty acids Nutrition 0.000 description 19
- 239000000194 fatty acid Substances 0.000 description 19
- 229930195729 fatty acid Natural products 0.000 description 19
- 150000004665 fatty acids Chemical class 0.000 description 19
- 239000006210 lotion Substances 0.000 description 12
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 8
- 239000008347 soybean phospholipid Substances 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 230000037393 skin firmness Effects 0.000 description 7
- 150000005846 sugar alcohols Polymers 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 125000004122 cyclic group Chemical group 0.000 description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 238000001556 precipitation Methods 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 3
- 229920000858 Cyclodextrin Polymers 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 3
- 230000009759 skin aging Effects 0.000 description 3
- 230000002123 temporal effect Effects 0.000 description 3
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- 235000021314 Palmitic acid Nutrition 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 150000001340 alkali metals Chemical group 0.000 description 2
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 2
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 235000015278 beef Nutrition 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 239000008344 egg yolk phospholipid Substances 0.000 description 2
- 229940068998 egg yolk phospholipid Drugs 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- 229960004488 linolenic acid Drugs 0.000 description 2
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 2
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 2
- 229920000166 polytrimethylene carbonate Polymers 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 238000007665 sagging Methods 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 239000003760 tallow Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- RYCNUMLMNKHWPZ-SNVBAGLBSA-N 1-acetyl-sn-glycero-3-phosphocholine Chemical compound CC(=O)OC[C@@H](O)COP([O-])(=O)OCC[N+](C)(C)C RYCNUMLMNKHWPZ-SNVBAGLBSA-N 0.000 description 1
- RMTFNDVZYPHUEF-XZBKPIIZSA-N 3-O-methyl-D-glucose Chemical compound O=C[C@H](O)[C@@H](OC)[C@H](O)[C@H](O)CO RMTFNDVZYPHUEF-XZBKPIIZSA-N 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 235000021319 Palmitoleic acid Nutrition 0.000 description 1
- 102000011420 Phospholipase D Human genes 0.000 description 1
- 108090000553 Phospholipase D Proteins 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- 238000012644 addition polymerization Methods 0.000 description 1
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- HQABUPZFAYXKJW-UHFFFAOYSA-O butylazanium Chemical compound CCCC[NH3+] HQABUPZFAYXKJW-UHFFFAOYSA-O 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- 229940113120 dipropylene glycol Drugs 0.000 description 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 1
- 229940090949 docosahexaenoic acid Drugs 0.000 description 1
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 1
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 1
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 239000008309 hydrophilic cream Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000011968 lewis acid catalyst Substances 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 1
- 229960002969 oleic acid Drugs 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 239000003444 phase transfer catalyst Substances 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- QEMXHQIAXOOASZ-UHFFFAOYSA-N tetramethylammonium Chemical compound C[N+](C)(C)C QEMXHQIAXOOASZ-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-O triethanolammonium Chemical compound OCC[NH+](CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-O 0.000 description 1
- ZMANZCXQSJIPKH-UHFFFAOYSA-O triethylammonium ion Chemical compound CC[NH+](CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-O 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
Description
本発明は、肌にハリ感を与える効果、化粧ノリの改善効果に優れるとともに、経時安定性にも優れる皮膚化粧料に関する。 The present invention relates to a skin cosmetic that is excellent in the effect of imparting firmness to the skin and the effect of improving makeup, and also has excellent temporal stability.
近年の高齢化社会の急速な到来とともに、皮膚の老化現象に悩む消費者が増加している。皮膚の老化現象は、乾燥や加齢、紫外線などが原因で進行し、シミやくすみの増加、肌のハリ(弾力性)の低下、キメの乱れ、毛穴の開大などとして表れる。中でも、肌のハリ(弾力性)の低下はシワやたるみを引き起こし、見た目年齢を引き上げ「老けた」印象を与える。そのため、肌にハリ感を与え、シワやたるみを改善する皮膚化粧料が求められている。 With the rapid arrival of an aging society in recent years, an increasing number of consumers suffer from skin aging. Skin aging progresses due to dryness, aging, ultraviolet rays, etc., and appears as an increase in spots and dullness, a decrease in skin firmness (elasticity), texture irregularities, and pore enlargement. Above all, the decrease in the elasticity (elasticity) of the skin causes wrinkles and sagging, raises the appearance age and gives the impression of “old”. Therefore, there is a demand for skin cosmetics that give the skin firmness and improve wrinkles and sagging.
一方、最近では女性の社会進出などにより、いわゆる「時短美容」が注目され、スキンケアステップの簡素化が好まれる傾向にあり、化粧水や乳液、クリーム、化粧下地の機能を集約した、「ツーインワン」や「オールインワン」タイプの化粧料が上市されている。通常、このような商品は、朝の化粧をより短時間で行いたい人たちに適しており、「朝用」の化粧料として使用されることが多い。そのため「朝用」の化粧料として重要視される化粧下地料の機能(化粧ノリの良さや化粧崩れの防止等)についても強く求められる傾向にある。 On the other hand, with the recent advancement of women in society, so-called "short-time beauty" has been attracting attention, and there is a tendency to simplify the skin care step, and the functions of lotion, milky lotion, cream, and makeup base have been consolidated. And “all-in-one” type cosmetics are on the market. Usually, such products are suitable for people who want to make up their morning makeup in a shorter time, and are often used as “morning” cosmetics. For this reason, there is a tendency to strongly demand the functions of makeup base materials regarded as important for “morning” cosmetics (such as good makeup and prevention of makeup collapse).
そのような状況下、皮膚の老化現象の抑制が期待される成分を配合した皮膚化粧料が種々提案されている。中でも、1−アシル−2,3−環状ホスファチジン酸またはその塩がヒアルロン酸産生増強作用を示すことが確認されており、この成分を配合した皮膚化粧料が提案されている(例えば、特許文献1)。
しかしながら、1−アシル−2,3−環状ホスファチジン酸またはその塩は、水への溶解性が低く、沈殿などを生じることがあるため、皮膚化粧料に配合した場合に、その効果を十分に発揮しているとは言い難かった。
Under such circumstances, various skin cosmetics containing ingredients expected to suppress the skin aging phenomenon have been proposed. Among these, it has been confirmed that 1-acyl-2,3-cyclic phosphatidic acid or a salt thereof exhibits a hyaluronic acid production enhancing action, and skin cosmetics containing this component have been proposed (for example, Patent Document 1). ).
However, 1-acyl-2,3-cyclic phosphatidic acid or a salt thereof has low solubility in water and may cause precipitation. It was hard to say.
そこで、水への溶解性を高めるために、特許文献2には、1−アシル−2,3−環状ホスファチジン酸またはその塩がリポソームの構成成分として配合された皮膚化粧料が提案されている。この皮膚化粧料では、水への溶解性の改善が見られるものの、肌にハリ感を与える効果が弱く、また化粧ノリを改善する効果が不十分であった。 Therefore, in order to enhance solubility in water, Patent Document 2 proposes a skin cosmetic in which 1-acyl-2,3-cyclic phosphatidic acid or a salt thereof is blended as a component of liposomes. In this skin cosmetic, although the solubility in water is seen, the effect of giving the skin firmness is weak, and the effect of improving the makeup is insufficient.
本発明は、上記の課題に鑑み、肌にハリ感を与える効果、化粧ノリの改善効果に優れるとともに、経時安定性にも優れる皮膚化粧料を提供することを目的とする。 An object of this invention is to provide the skin cosmetics which are excellent in the effect which gives a firm feeling to the skin, the improvement effect of makeup flakes, and is excellent also in temporal stability in view of said subject.
上記課題を解決するために本発明者らが鋭意検討した結果、(a)式[I]で表される1−アシル−2,3−環状ホスファチジン酸またはその塩と、(b)エチレンオキサイドが特定の平均付加モル数であるポリオキシエチレンメチルグルコシドとを特定の比率で組み合わせることにより、上記課題を解決し得る皮膚化粧料が得られることを見出し、本発明を完成させるに至った。 As a result of intensive studies by the present inventors in order to solve the above problems, (a) 1-acyl-2,3-cyclic phosphatidic acid represented by the formula [I] or a salt thereof, and (b) ethylene oxide It discovered that the skin cosmetics which can solve the said subject were obtained by combining polyoxyethylene methyl glucoside which is a specific average addition mole number with a specific ratio, and came to complete this invention.
すなわち、本発明の皮膚化粧料は、(a)式[I]で表される1−アシル−2,3−環状ホスファチジン酸またはその塩を0.0001〜5質量%、(b)エチレンオキシドの平均付加モル数が15〜25のポリオキシエチレンメチルグルコシドを0.1〜15質量%にて含有する皮膚化粧料である。 That is, the skin cosmetic of the present invention comprises (a) 0.0001 to 5% by mass of 1-acyl-2,3-cyclic phosphatidic acid represented by the formula [I] or a salt thereof, and (b) an average of ethylene oxide. It is a skin cosmetic containing 0.1 to 15% by mass of polyoxyethylene methyl glucoside having an addition mole number of 15 to 25.
本発明の皮膚化粧料は、肌にハリ感を与える効果、化粧ノリの改善効果に優れるとともに、経時安定性にも優れる。 The skin cosmetic of the present invention is excellent in the effect of imparting firmness to the skin, the effect of improving the makeup flakes, and is excellent in stability over time.
以下、本発明の実施形態について説明する。
本発明の皮膚化粧料は、下記(a)および(b)成分を含有する。まず、(a)成分について説明する。
Hereinafter, embodiments of the present invention will be described.
The skin cosmetic of the present invention contains the following components (a) and (b). First, the component (a) will be described.
〔(a)式[I]で表される1−アシル−2,3−環状ホスファチジン酸またはその塩〕
本発明の皮膚化粧料に用いられる(a)成分は、式[I]で示される1−アシル−2,3−環状ホスファチジン酸またはその塩である。以下、「1−アシル−2,3−環状ホスファチジン酸またはその塩」を「置換環状ホスファチジン酸(塩)」とも表記する。
式[I]中、Rは炭素数10〜22のアシル基であり、好ましくは炭素数12〜20の直鎖状もしくは分岐鎖状の脂肪酸由来のアシル基である。
脂肪酸としては、例えば、カプリン酸、ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、イソステアリン酸等の飽和脂肪酸、パルミトレイン酸、オレイン酸、リノール酸、リノレン酸、アラキドン酸、エイコサペンタエン酸、ドコサヘキサエン酸等の不飽和脂肪酸、およびこれら脂肪酸の混合物が挙げられる。脂肪酸の混合物としては、ヤシ油脂肪酸、パーム核油脂肪酸、牛脂脂肪酸、硬化牛脂脂肪酸、大豆リン脂質由来脂肪酸、卵黄リン脂質由来脂肪酸が挙げられる。中でも好ましくは、大豆リン脂質由来脂肪酸、卵黄リン脂質由来脂肪酸であり、さらに好ましくは、大豆リン脂質由来脂肪酸である。
[(A) 1-acyl-2,3-cyclic phosphatidic acid represented by the formula [I] or a salt thereof]
The component (a) used in the skin cosmetic of the present invention is 1-acyl-2,3-cyclic phosphatidic acid represented by the formula [I] or a salt thereof. Hereinafter, “1-acyl-2,3-cyclic phosphatidic acid or a salt thereof” is also referred to as “substituted cyclic phosphatidic acid (salt)”.
In the formula [I], R is an acyl group having 10 to 22 carbon atoms, preferably an acyl group derived from a linear or branched fatty acid having 12 to 20 carbon atoms.
Examples of fatty acids include saturated fatty acids such as capric acid, lauric acid, myristic acid, palmitic acid, stearic acid, isostearic acid, palmitoleic acid, oleic acid, linoleic acid, linolenic acid, arachidonic acid, eicosapentaenoic acid, docosahexaenoic acid, etc. Unsaturated fatty acids, and mixtures of these fatty acids. Examples of the fatty acid mixture include coconut oil fatty acid, palm kernel oil fatty acid, beef tallow fatty acid, hardened beef tallow fatty acid, soybean phospholipid-derived fatty acid, and egg yolk phospholipid-derived fatty acid. Among them, preferred are soybean phospholipid-derived fatty acids and egg yolk phospholipid-derived fatty acids, and more preferred are soybean phospholipid-derived fatty acids.
本発明の皮膚化粧料に用いられる1−アシル−2,3−環状ホスファチジン酸塩は、下記式[II]で示されるものである。 The 1-acyl-2,3-cyclic phosphatidate used in the skin cosmetic of the present invention is represented by the following formula [II].
式[II]中のRは式[I]中のRと同義である。
式[II]中のMとしては、アルカリ金属原子、アンモニウム、有機アンモニウムなどが挙げられる。アルカリ金属原子としては、例えば、ナトリウム、カリウムが挙げられる。有機アンモニウムとしては、例えば、トリエタノールアンモニウム、ブチルアンモニウム、トリエチルアンモニウム、テトラメチルアンモニウムが挙げられる。これらの中でも、ナトリウム、カリウムが好ましい。
R in formula [II] has the same meaning as R in formula [I].
Examples of M in the formula [II] include an alkali metal atom, ammonium, and organic ammonium. Examples of the alkali metal atom include sodium and potassium. Examples of the organic ammonium include triethanolammonium, butylammonium, triethylammonium, and tetramethylammonium. Among these, sodium and potassium are preferable.
置換環状ホスファチジン酸(塩)の製造方法としては、例えば、リゾホスファチジルコリンをホスホリパーゼDで酵素処理する方法、化学合成にて調製する方法(特開平6−228169号公報等を参照)等が挙げられる。 Examples of the method for producing a substituted cyclic phosphatidic acid (salt) include a method in which lysophosphatidylcholine is treated with phospholipase D, a method in which it is prepared by chemical synthesis (see JP-A-6-228169, etc.), and the like.
また、本発明の皮膚化粧料に用いられる置換環状ホスファチジン酸(塩)の純度や形態は特に限定されない。例えば、純品のもの、賦形剤を含有するもの、液体のもの、粉体のものを用いることが可能である。具体的には、賦形剤としてシクロデキストリンを用いて凍結乾燥により得られた、1−アシル−2,3−環状ホスファチジン酸を含有する粉体が挙げられる。この凍結乾燥方法によれば、賦形剤によりさらさらとした取り扱いやすい脂質とすることが可能である。
置換環状ホスファチジン酸(塩)は1種又は2種以上を用いることができる。
The purity and form of the substituted cyclic phosphatidic acid (salt) used in the skin cosmetic of the present invention are not particularly limited. For example, pure products, those containing excipients, liquids, and powders can be used. Specifically, powder containing 1-acyl-2,3-cyclic phosphatidic acid obtained by lyophilization using cyclodextrin as an excipient can be mentioned. According to this freeze-drying method, it is possible to obtain a lipid that is easy to handle and is easy to handle with an excipient.
1 type (s) or 2 or more types can be used for a substituted cyclic phosphatidic acid (salt).
なお、1−アシル−2,3−環状ホスファチジン酸は、商業的には、日油株式会社製「CyPA−ET」、「CyPA−PW」として入手することができる。「CyPA−ET」および「CyPA−PW」は、いずれも大豆リン脂質由来脂肪酸のアシル基である1−アシル−2,3−環状ホスファチジン酸を含有する。大豆リン脂質由来脂肪酸の脂肪酸組成は、パルミチン酸20.4質量%、ステアリン酸3.2質量%、オレイン酸11.3質量%、リノール酸57.6質量%、リノレン酸6.1質量%、その他1.4質量%である。 In addition, 1-acyl-2,3-cyclic phosphatidic acid can be obtained commercially as “CyPA-ET” and “CyPA-PW” manufactured by NOF Corporation. “CyPA-ET” and “CyPA-PW” both contain 1-acyl-2,3-cyclic phosphatidic acid, which is an acyl group of fatty acid derived from soybean phospholipid. The fatty acid composition of the fatty acid derived from soybean phospholipid is as follows: palmitic acid 20.4% by mass, stearic acid 3.2% by mass, oleic acid 11.3% by mass, linoleic acid 57.6% by mass, linolenic acid 6.1% by mass, Others are 1.4% by mass.
(a)成分の含有量は、皮膚化粧料に対して、0.0001〜5質量%であり、好ましくは0.001〜2質量%、さらに好ましくは0.05〜1質量%である。含有量が少なすぎると、肌にハリ感を与える効果や化粧ノリの改善効果が低下するおそれがあり、含有量が多すぎると、経時安定性が低下するおそれがある。 (A) Content of a component is 0.0001-5 mass% with respect to skin cosmetics, Preferably it is 0.001-2 mass%, More preferably, it is 0.05-1 mass%. If the content is too small, the effect of imparting firmness to the skin and the effect of improving makeup flesh may be reduced, and if the content is too large, the stability over time may be reduced.
〔(b)ポリオキシエチレンメチルグルコシド〕
本発明の皮膚化粧料に用いられる(b)成分は、エチレンオキシドの平均付加モル数が15〜25のポリオキシエチレンメチルグルコシドである。エチレンオキシドの平均付加モル数は15〜25であり、好ましくは17〜23であり、さらに好ましくは18〜22である。エチレンオキシドの平均付加モル数が小さすぎると、経時安定性が低下するおそれがあり、大きすぎると、化粧ノリの改善効果が低下するおそれがある。
なお、平均付加モル数とは、メチルグルコシド1モルに対するエチレンオキシドの総平均付加モル数を示す。ポリオキシエチレンメチルグルコシドは1種又は2種以上を用いることができる。
[(B) Polyoxyethylene methyl glucoside]
(B) component used for the skin cosmetics of this invention is polyoxyethylene methyl glucoside whose average addition mole number of ethylene oxide is 15-25. The average added mole number of ethylene oxide is 15 to 25, preferably 17 to 23, and more preferably 18 to 22. If the average added mole number of ethylene oxide is too small, the stability over time may be lowered, and if it is too large, the effect of improving the makeup paste may be lowered.
The average added mole number indicates the total average added mole number of ethylene oxide with respect to 1 mole of methyl glucoside. The polyoxyethylene methyl glucoside can use 1 type (s) or 2 or more types.
ポリオキシエチレンメチルグルコシドは、公知の方法により製造することができ、通常、相関移動触媒、ルイス酸触媒、アルカリ触媒等を用いてメチルグルコースにエチレンオキサイドを付加重合させることにより得ることができる。一般的には水酸化カリウム等のアルカリ触媒を使用することが好ましい。
ポリオキシエチレンメチルグルコシドの具体的な市販品としては、例えば、ポリオキシエチレン(20)メチルグルコシド(日油株式会社製の「マクビオブライドMG−20E」および日本ルーブリゾール株式会社製の「GLUCAM E−20」)が挙げられる。
Polyoxyethylene methyl glucoside can be produced by a known method, and can usually be obtained by addition polymerization of ethylene oxide to methyl glucose using a phase transfer catalyst, a Lewis acid catalyst, an alkali catalyst or the like. In general, it is preferable to use an alkali catalyst such as potassium hydroxide.
Specific examples of commercially available polyoxyethylene methyl glucoside include, for example, polyoxyethylene (20) methyl glucoside (“Macbiobride MG-20E” manufactured by NOF Corporation and “GLUCAM E” manufactured by Nippon Lubrizol Corporation. -20 ").
(b)成分の含有量は、皮膚化粧料に対して、0.1〜15質量%であり、好ましくは2〜10質量%、さらに好ましくは3〜7質量%である。含有量が少なすぎると、肌にハリ感を与える効果や経時安定性が低下するおそれがあり、含有量が多すぎると、化粧ノリの改善効果が低下するおそれがある。 (B) Content of a component is 0.1-15 mass% with respect to skin cosmetics, Preferably it is 2-10 mass%, More preferably, it is 3-7 mass%. If the content is too small, the effect of imparting firmness to the skin and the stability over time may be reduced, and if the content is too high, the effect of improving makeup flesh may be reduced.
〔(c)多価アルコール〕
本発明の皮膚化粧料は、上記の(a)成分および(b)成分に加えて、(c)成分として多価アルコールをさらに含有していても良い。かかる多価アルコールとしては、炭素数が3〜6である2〜4価のアルコール、言い換えれば炭素数3〜6であり水酸基が2〜4個の水溶性アルコールが挙げられる。具体的には、例えば、1,2−プロパンジオール、1,3−プロパンジオール、1,3−ブチレングリコール、1,2−ペンタンジオール、ヘキシレングリコール、ジプロピレングリコール、グリセリン、ジグリセリン等が挙げられる。中でも好ましくは、1,3−プロパンジオール、1,3−ブチレングリコール、1,2−ペンタンジオール、ジプロピレングリコール、グリセリンである。これら多価アルコールは1種又は2種以上を用いることができる。
[(C) polyhydric alcohol]
The skin cosmetic of the present invention may further contain a polyhydric alcohol as the component (c) in addition to the components (a) and (b). Examples of such polyhydric alcohols include divalent to tetravalent alcohols having 3 to 6 carbon atoms, in other words, water-soluble alcohols having 3 to 6 carbon atoms and 2 to 4 hydroxyl groups. Specific examples include 1,2-propanediol, 1,3-propanediol, 1,3-butylene glycol, 1,2-pentanediol, hexylene glycol, dipropylene glycol, glycerin, diglycerin and the like. It is done. Among these, 1,3-propanediol, 1,3-butylene glycol, 1,2-pentanediol, dipropylene glycol, and glycerin are preferable. These polyhydric alcohols can be used alone or in combination of two or more.
本発明の皮膚化粧料が(c)成分として多価アルコールをさらに含有する場合、(c)成分の含有量は、皮膚化粧料に対して、1〜20質量%であり、好ましくは3〜18質量%、更に好ましくは5〜15質量%である。(c)成分の含有量を上記範囲とすることにより、肌にハリ感を与える効果および化粧ノリの改善効果をさらに高めることができる。 When the skin cosmetic of the present invention further contains a polyhydric alcohol as the component (c), the content of the component (c) is 1 to 20% by mass, preferably 3 to 18% with respect to the skin cosmetic. % By mass, more preferably 5 to 15% by mass. By making content of (c) component into the said range, the effect which gives a firm feeling to skin, and the improvement effect of a makeup flesh can be further heightened.
本発明の皮膚化粧料は、上記の(a)成分〜(c)成分に加えて、通常は水を含有し、通常の方法に従って、上記(a)および(b)成分、場合によりさらに(c)成分と水とを混合することで調製することができる。また、本発明の皮膚化粧料には、本発明の効果を損なわない範囲で、化粧料に常用されている他の成分を配合することができる。
本発明の皮膚化粧料は、例えば、化粧水、乳液、ジェル、クリーム、美容液、化粧下地料等に適用することができる。
The skin cosmetic of the present invention usually contains water in addition to the above-mentioned components (a) to (c), and the components (a) and (b) and optionally (c) ) It can be prepared by mixing the component and water. In addition, the skin cosmetic of the present invention can be blended with other components commonly used in cosmetics as long as the effects of the present invention are not impaired.
The skin cosmetic of the present invention can be applied to, for example, lotion, milky lotion, gel, cream, cosmetic liquid, cosmetic base material, and the like.
以下、実施例および比較例を挙げて本発明をさらに具体的に説明する。なお、以下の「%」は「質量%」を意味する。 Hereinafter, the present invention will be described more specifically with reference to examples and comparative examples. The following “%” means “mass%”.
〔実施例1〜6、および比較例1〜4〕
皮膚化粧料として、表1に示す成分を用いて通常の方法に従い化粧水を調製し、下記の方法により化粧水の評価を行った。その結果を表1に示す。
なお、表中の記号は下記の商品を示す。
※1:日油株式会社製「CyPA−ET」:大豆リン脂質由来脂肪酸のアシル基である1−アシル−2,3−環状ホスファチジン酸を4質量%、エタノールを40質量%含有する水溶液。なお、表中の(製品)の数値は製品である「CyPA−ET」の濃度を表す。
※2:日油株式会社製「CyPA−PW」:大豆リン脂質由来脂肪酸のアシル基である1−アシル−2,3−環状ホスファチジン酸を10質量%、シクロデキストリンを50質量%含有する粉末。なお、表中の(製品)の数値は製品である「CyPA−PW」の濃度を表す。
※3:日油株式会社製「マクビオブライドMG−20E」
なお、化合物名中の(20)は平均付加モル数が20モルであることを示す。
※4:日油株式会社製「マクビオブライドMG−10E」
なお、化合物名中の(10)は平均付加モル数が20モルであることを示す。
※5:日油株式会社製「マクビオブライドMG−20P」
なお、化合物名中の(20)は平均付加モル数が20モルであることを示す。
[Examples 1 to 6 and Comparative Examples 1 to 4]
As a skin cosmetic, a lotion was prepared according to the usual method using the components shown in Table 1, and the lotion was evaluated by the following method. The results are shown in Table 1.
In addition, the symbol in a table | surface shows the following goods.
* 1: “CyPA-ET” manufactured by NOF Corporation: An aqueous solution containing 4% by mass of 1-acyl-2,3-cyclic phosphatidic acid, which is an acyl group of soybean phospholipid-derived fatty acid, and 40% by mass of ethanol. In addition, the numerical value of (product) in a table | surface represents the density | concentration of "CyPA-ET" which is a product.
* 2: “CyPA-PW” manufactured by NOF Corporation: Powder containing 10% by mass of 1-acyl-2,3-cyclic phosphatidic acid, which is an acyl group of soybean phospholipid-derived fatty acid, and 50% by mass of cyclodextrin. The numerical value of (Product) in the table represents the concentration of “CyPA-PW” as a product.
* 3: NOF Corporation's “Macbiobride MG-20E”
In addition, (20) in a compound name shows that an average addition mole number is 20 mol.
* 4: “Macbiobride MG-10E” manufactured by NOF Corporation
In addition, (10) in a compound name shows that an average addition mole number is 20 mol.
* 5: NOF Corporation “McBioride MG-20P”
In addition, (20) in a compound name shows that an average addition mole number is 20 mol.
(1)肌にハリ感を与える効果
20名の女性(30〜48歳)をパネラーとし、上記化粧水を朝夕の洗顔後の1日2回、全顔に1週間塗布し続け、1週間後の朝に化粧水(皮膚化粧料)を塗布する前、肌のハリ感についてパネラーが下記のとおりに評価した。
2点:肌のハリ感が明らかに向上してきたと感じた場合。
1点:肌のハリ感がやや向上してきたと感じた場合。
0点:肌のハリ感に変化がない、または悪くなったと感じた場合。
(1) The effect of giving firmness to the skin 20 women (30 to 48 years old) are panelists, and the above lotion is applied twice a day after face washing in the morning and evening for 1 week, 1 week later Before applying skin lotion (skin cosmetic) on the morning of this morning, the panelist evaluated the skin firmness as follows.
2 points: When the skin feels clearly improved.
1 point: When the skin feels somewhat improved.
0 points: When the skin feels unchanged or feels worse.
20名の合計点を求め、以下のように評価した。
◎:合計点が35点以上:肌にハリ感を強く与える皮膚化粧料である。
○:合計点が25点以上35点未満:肌にハリ感を与える皮膚化粧料である。
△:合計点が15点以上25点未満:肌にハリ感をやや与える皮膚化粧料である。
×:合計点が15点未満:肌にハリ感を与えない皮膚化粧料である。
The total score of 20 people was calculated and evaluated as follows.
A: Total score of 35 or more: A skin cosmetic that strongly gives a firm feeling to the skin.
◯: Total score of 25 points or more and less than 35 points: A skin cosmetic that gives a firm feeling to the skin.
(Triangle | delta): The total score is 15 points or more and less than 25 points: It is skin cosmetics which give the skin a little firmness.
X: The total score is less than 15: It is a skin cosmetic that does not give a firm feeling to the skin.
(2)化粧ノリの改善効果
20名の女性(30〜48歳)をパネラーとし、上記化粧水を朝夕の洗顔後の1日2回、全顔に1週間塗布し続け、1週間後の朝に化粧水(皮膚化粧料)を塗布した後、各自が普段使用しているファンデーションを全顔に塗布し、化粧ノリについてパネラーが下記のとおりに評価した。
2点:化粧ノリが改善したと感じた場合。
1点:僅かに化粧ノリが改善したと感じた場合。
0点:化粧ノリに変化がない、または悪くなったと感じた場合。
(2) Improvement effect of makeup glue 20 females (30 to 48 years old) are panelists, and the above lotion is applied to all faces once a day after washing face in the morning and evening for 1 week. After applying lotion (skin cosmetic) on the face, the foundation that they normally use was applied to the entire face, and the panelists evaluated the makeup paste as follows.
2 points: When the makeup feels improved.
1 point: When the makeup feeling is slightly improved.
0 point: When it is felt that there is no change or worsening in the makeup.
20名のパネラーについての評価の合計点を求め、以下のとおりに判定した。
◎:合計点が35点以上:化粧ノリの改善効果に非常に優れる皮膚化粧料である。
○:合計点が25点以上35点未満:化粧ノリの改善効果に優れる皮膚化粧料である。
△:合計点が15点以上25点未満:化粧ノリの改善効果が僅かに得られる皮膚化粧料である。
×:合計点が15点未満:化粧ノリの改善効果が得られない皮膚化粧料である。
The total score of the evaluation for 20 panelists was determined and determined as follows.
A: The total score is 35 points or more: a skin cosmetic that is extremely excellent in the effect of improving makeup flakes.
◯: Total score of 25 points or more and less than 35 points: A skin cosmetic excellent in the improvement effect of makeup flakes.
(Triangle | delta): The total score is 15 points or more and less than 25 points: It is skin cosmetics from which the improvement effect of makeup flakes is acquired slightly.
X: The total score is less than 15: It is a skin cosmetic that does not provide an effect of improving makeup flakes.
(3)経時安定性
上記化粧水(皮膚化粧料)をガラス容器に密閉して室温で1週間放置した後、外観を肉眼にて観察し、下記のように評価した。
○:安定性良好(外観の変化がなく、粒なども生じていない。)
△:安定性やや不良(僅かに沈殿が生じるか、または僅かに粒が析出している。)
×:安定性不良(明らかに沈殿が生じるか、または粒が析出している。)
(3) Stability over time After the above lotion (skin cosmetic) was sealed in a glass container and allowed to stand at room temperature for 1 week, the appearance was observed with the naked eye and evaluated as follows.
○: Good stability (no change in appearance, no grain, etc.)
Δ: Slightly inferior (slight precipitation or slight grain precipitation)
×: Stability failure (clearly precipitation occurs or grains are precipitated)
表1に示す実施例1〜6の結果から、本発明の皮膚化粧料に係る化粧水は、いずれも肌にハリ感を与える効果、化粧ノリの改善効果に優れるとともに、経時安定性に優れていることが理解できる。 From the results of Examples 1 to 6 shown in Table 1, the lotions according to the skin cosmetics of the present invention are all excellent in the effect of giving the skin firmness, the effect of improving the makeup flakes, and excellent in the stability over time. I can understand that.
一方、比較例1〜4では十分な性能が得られていない。
具体的には、比較例1では、(b)成分に代えて、エチレンオキシドの平均付加モル数が本発明規定の下限値よりも小さいポリオキシエチレンメチルグルコシドが配合されていることから、経時安定性が不十分である。
比較例2では、(b)成分に代えて、プロピレンオキシドが平均で20モル付加したポリオキシプロピレンメチルグルコシドが配合されていることから、経時安定性が不十分である。
比較例3では、(a)成分が配合されていないことから、化粧ノリの改善効果が不十分であり、肌にハリ感を与える効果が得られていない。
比較例4では、(b)成分の含有量が本発明規定の上限値を超えていることから、化粧ノリの改善効果が不十分である。
On the other hand, in Comparative Examples 1-4, sufficient performance is not obtained.
Specifically, in Comparative Example 1, instead of the component (b), polyoxyethylene methyl glucoside having an average added mole number of ethylene oxide smaller than the lower limit defined in the present invention is blended. Is insufficient.
In Comparative Example 2, instead of the component (b), polyoxypropylene methylglucoside added with an average of 20 moles of propylene oxide is blended, so that the temporal stability is insufficient.
In Comparative Example 3, since the component (a) is not blended, the effect of improving the makeup flare is insufficient, and the effect of giving the skin firmness is not obtained.
In Comparative Example 4, since the content of the component (b) exceeds the upper limit specified in the present invention, the effect of improving the makeup paste is insufficient.
〔実施例7〕
表2に示す配合比率で、常法に従って、水中油型クリームである皮膚化粧料を調製した。得られた皮膚化粧料を用いて、上記実施例と同様の方法により3項目について評価を行った。結果を表2に示す。
Example 7
Skin cosmetics that are oil-in-water creams were prepared according to conventional methods at the blending ratios shown in Table 2. Using the obtained skin cosmetics, three items were evaluated by the same method as in the above Examples. The results are shown in Table 2.
※2:日油株式会社製「CyPA−PW」:大豆リン脂質由来脂肪酸のアシル基である1−アシル−2,3−環状ホスファチジン酸を10質量%、シクロデキストリンを50質量%含有する粉末。なお、表中の(製品)の数値は製品である「CyPA−PW」の濃度を表す。
※3:日油株式会社製「マクビオブライドMG−20E」
なお、化合物名中の(20)は平均付加モル数が20モルであることを示す。
* 2: “CyPA-PW” manufactured by NOF Corporation: Powder containing 10% by mass of 1-acyl-2,3-cyclic phosphatidic acid, which is an acyl group of soybean phospholipid-derived fatty acid, and 50% by mass of cyclodextrin. The numerical value of (Product) in the table represents the concentration of “CyPA-PW” as a product.
* 3: NOF Corporation's “Macbiobride MG-20E”
In addition, (20) in a compound name shows that an average addition mole number is 20 mol.
表2に示す実施例7の結果から、本発明の皮膚化粧料に係るクリームは、肌にハリ感を与える効果、化粧ノリの改善効果に優れるとともに、経時安定性にも優れていることが理解できる。 From the results of Example 7 shown in Table 2, it is understood that the cream according to the skin cosmetics of the present invention is excellent in the effect of giving the skin firmness, the improvement effect of the makeup flakes, and excellent in the stability over time. it can.
Claims (1)
(b)エチレンオキシドの平均付加モル数が15〜25のポリオキシエチレンメチルグルコシドを0.1〜15質量%にて含有する皮膚化粧料。
(B) A skin cosmetic containing 0.1 to 15% by mass of polyoxyethylene methylglucoside having an average addition mole number of ethylene oxide of 15 to 25.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2014263674A JP6443040B2 (en) | 2014-12-25 | 2014-12-25 | Skin cosmetics |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2014263674A JP6443040B2 (en) | 2014-12-25 | 2014-12-25 | Skin cosmetics |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2016121118A JP2016121118A (en) | 2016-07-07 |
JP6443040B2 true JP6443040B2 (en) | 2018-12-26 |
Family
ID=56328092
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2014263674A Active JP6443040B2 (en) | 2014-12-25 | 2014-12-25 | Skin cosmetics |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6443040B2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2019119706A (en) * | 2018-01-05 | 2019-07-22 | 花王株式会社 | Comfort feeling improver |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4876334B2 (en) * | 2001-06-06 | 2012-02-15 | 日油株式会社 | Hyaluronic acid production capacity enhancer and use thereof |
JP4751013B2 (en) * | 2003-08-04 | 2011-08-17 | 花王株式会社 | Solubilized cosmetics |
JP2006016305A (en) * | 2004-06-30 | 2006-01-19 | Masashi Fujii | External preparation for skin purposing beautification such as aging prevention |
JP2006273814A (en) * | 2005-03-30 | 2006-10-12 | Naris Cosmetics Co Ltd | Coenzyme q10-containing water-based composition |
JP5326216B2 (en) * | 2007-03-13 | 2013-10-30 | 日油株式会社 | Liposomes for cosmetics |
-
2014
- 2014-12-25 JP JP2014263674A patent/JP6443040B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2016121118A (en) | 2016-07-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6130121B2 (en) | Emulsifying cleansing cosmetic | |
JP5872838B2 (en) | Antibacterial composition | |
JP5690208B2 (en) | External preparation for skin and method for producing the same | |
JP5693245B2 (en) | Topical skin preparation | |
JP6036188B2 (en) | Cleansing cream | |
JP2014028762A (en) | Emulsion type cleansing cosmetic | |
JP2016060716A (en) | Opaque cosmetic | |
JP6443040B2 (en) | Skin cosmetics | |
JP2013001698A (en) | Oily gel cleansing composition | |
JP7338471B2 (en) | detergent composition | |
JP6225600B2 (en) | Topical skin preparation | |
KR101535327B1 (en) | Emulsion Cosmetic Composition Having Liquid Crystal Structure | |
TWI772333B (en) | Composition containing linoleic acid | |
JP2013032302A (en) | External preparation for skin and method for producing the same | |
JP6662606B2 (en) | Skin cosmetic composition | |
JP5865623B2 (en) | External preparation for skin and method for producing the same | |
JP6299209B2 (en) | Topical skin preparation | |
JP5997517B2 (en) | Aqueous cosmetics | |
JP5495852B2 (en) | Topical skin preparation | |
KR101812335B1 (en) | Emulsified composition | |
JP5865624B2 (en) | External preparation for skin and method for producing the same | |
JP2019014703A (en) | Linoleic acid-containing composition | |
JP2022151457A (en) | skin composition | |
JP2017197510A (en) | Liquid composition | |
JP4529402B2 (en) | Skin cosmetics |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20171106 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20180731 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20180807 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20181030 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20181112 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6443040 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |